O'Donnell S R, Persson C G, Wanstall J C
Br J Pharmacol. 1978 Feb;62(2):227-33. doi: 10.1111/j.1476-5381.1978.tb08450.x.
1 A comparison of six beta-adrenoceptor stimulants has been carried out on in vitro preparations of guinea-pig uterus which were depolarized in K(+)-Krebs solution. Results have also been obtained on uterine preparations in which contractions to acetylcholine were inhibited. The establishment of the conditions for the K(+)-depolarized preparations are described.2 There was no significant difference between potency values (mean neg log EC(50) values) for any of the drugs on the two types of uterine preparation i.e. the preparations had the same sensitivity to the drugs.3 There was a less than two-fold difference between the relative potency values for the beta-adrenoceptor stimulants on the two types of uterine preparation. The relative potency values (isoprenaline = 100) on the K(+)-depolarized preparation were fenoterol 74.1, salbutamol 15.1, rimiterol 13.5, terbutaline 8.2 and orciprenaline 5.6.4 The relative potency values obtained on uterine preparations were less than three-fold different from those previously found for guinea-pig trachea (after inhibition of extraneuronal uptake).5 The pA(2) value for propranolol on the K(+)-depolarized uterine preparations was 9.13.6 It is concluded that the K(+)-depolarized guinea-pig uterine preparation can be used for quantitative studies on beta-adrenoceptor stimulant drugs. It lacks spontaneous activity, drugs can be added cumulatively and several drugs can be compared on a single preparation. In addition, the results obtained support the classification of the beta-adrenoceptors in guinea-pig uterus and trachea in the same sub-group (beta(2)).
已对在K⁺- Krebs溶液中去极化的豚鼠子宫体外制剂进行了六种β-肾上腺素受体激动剂的比较。还获得了对乙酰胆碱收缩反应受到抑制的子宫制剂的结果。描述了K⁺去极化制剂条件的建立。
两种类型的子宫制剂上任何一种药物的效价(平均负对数EC₅₀值)之间无显著差异,即制剂对药物的敏感性相同。
两种类型的子宫制剂上β-肾上腺素受体激动剂的相对效价值之间的差异小于两倍。在K⁺去极化制剂上的相对效价值(异丙肾上腺素=100)分别为非诺特罗74.1、沙丁胺醇15.1、利米特罗13.5、特布他林8.2和奥西那林5.6。
在子宫制剂上获得的相对效价值与先前在豚鼠气管(抑制神经元外摄取后)中发现的相对效价值的差异小于三倍。
普萘洛尔在K⁺去极化子宫制剂上的pA₂值为9.13。
得出结论,K⁺去极化的豚鼠子宫制剂可用于β-肾上腺素受体激动剂药物的定量研究。它缺乏自发活动,药物可累积添加,并且可以在单个制剂上比较几种药物。此外,获得的结果支持将豚鼠子宫和气管中的β-肾上腺素受体分类在同一亚组(β₂)中。